Amy C. Moore, Director of Patient Engagement and Advocacy at Summit Therapeutics, shared a post on LinkedIn:
“On this first-ever Cancer Cachexia Awareness Day, it is timely that Team CANCAN members Yvonne Diaz and Dr. Richard Dunne are presenting our work for LUNGevity Foundation’s ILCSC25. Approximately 80% of patients with advanced cancer will experience cachexia. Get the facts.”
Oncogene Cancer Research shared this post, adding:
”Pleasure to join LUNGevity Foundation’s International Lung Cancer Survivorship Conference today to speak about cachexia. Well timed with the first Cancer Cachexia Awareness Day.
You can also learn more about the work of Cancer Grand Challenges’ Team CANCAN and access our patient resources here.”
More posts featuring Oncogene Cancer Research on OncoDaily.
